PropertyValue
?:abstract
  • Bacterial coinfection in COVID-19 patients has the potential to complicate treatments and accelerate the development of antibiotic resistance in the clinic due to the widespread use of broad-spectrum antibiotics, including in Indonesia. The surge of COVID-19 patients may worsen antibiotic overuse; therefore, information on the actual extent of bacterial coinfection in COVID-19 patients in Indonesia is crucial to inform appropriate treatment. This Viewpoint elaborates on a nascent research project focused on sequencing of swab samples to detect bacterial coinfection in COVID-19 patients in Indonesia. Supported by a L’Oréal-UNESCO For Women in Science National Fellowship, it is designed to inform better clinical management of COVID-19 in Indonesia.
?:creator
?:doi
  • 10.1021/acsinfecdis.1c00006
?:doi
?:journal
  • ACS_Infect_Dis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/2c5ccaaf80834ac2585d9bc61ded4b0822383f92.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7860142.xml.json
?:pmcid
?:pmid
?:pmid
  • 33502840.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia
?:type
?:year
  • 2021-01-27

Metadata

Anon_0  
expand all